To identify the c-Met signaling effector responsible for HHLA2-promoted HCC metastasis (metastasis and angiogenesis being the most prominent HHLA2-induced phenotypes), we examined the effect of HHLA2 overexpression in HepG2 cells. The gene discussed is HHLA2; the disease is hepatocellular carcinoma.